IL-29 Monoclonal antibody

IL-29 Monoclonal Antibody for WB, ELISA
Cat No. 66163-1-Ig

产品说明书

CloneNo. 1H3A3

宿主/亚型

Mouse / IgG1

种属反应性

human

应用

WB, ELISA

Cytokine Zcyto21, IFN lambda 1, IFNL1, IL 29, IL29, IL-29, Interferon lambda 1, Interleukin 29, ZCYTO21

缓冲液配方:  PBS and Azide
PBS and Azide
PBS Only
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive WB detected inRecombinant protein

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:5000-1:50000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

66163-1-Ig targets IL-29 in WB, ELISA applications and shows reactivity with human samples.

经测试应用 WB, ELISA Application Description
经测试反应性 human
免疫原 IL-29 fusion protein Ag12444 种属同源性预测
宿主/亚型 Mouse / IgG1
抗体类别 Monoclonal
产品类型 Antibody
全称 interleukin 29 (interferon, lambda 1)
别名 Cytokine Zcyto21, IFN lambda 1, IFNL1, IL 29, IL29, IL-29, Interferon lambda 1, Interleukin 29, ZCYTO21
计算分子量 200 aa, 22 kDa
观测分子量 22 kDa
GenBank蛋白编号BC074985
基因名称 IL-29
Gene ID (NCBI) 282618
RRIDAB_2881559
偶联类型 Unconjugated
形式 Liquid
纯化方式Protein G purification
UNIPROT IDQ8IU54
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

Interleukin-29 (IL-29) is a cytokine belonging to the Type III interferon family, which has another two subfamilies IL-28A and IL-28B. They are also known as IFN-λ1, IFN-λ2 and IFN-λ3, respectively. IL-29 is produced predominantly by maturing dendritic cells and macrophages. IL-29 plays an important role in the immune response against pathogenes and especially against viruses by mechanisms similar to type I interferons. IL-29 receptor signals through JAK-STAT pathways leading to activated expression of interferon-stimulated genes and production of antiviral proteins.

实验方案

Product Specific Protocols
WB protocol for IL-29 antibody 66163-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...